Table 2.

Responsiveness of the gamma-glutamyl transpeptidase to platelet ratio (GPR), aspartate aminotransferase to platelet ratio Index (APRI) and fibrosis index based on four factors (FIB-4) during treatment of nucleoside/nucleotide analogues (NAs)

	Spearman’s r	p Value
ΔGPR* and Δscore †	0.58	p<0.001
ΔAPRI‡ and Δscore	0.45	p<0.001
ΔFIB-4§and Δscore	0.39	p<0.001

*Change in GPR between two liver biopsies during treatment of NAs.

†Change in METAVIR liver fibrosis score between two liver biopsies during treatment of NAs.

‡Change in APRI between two liver biopsies during treatment of NAs.

§Change in FIB-4 between two liver biopsies during treatment of NAs.

APRI, aspartate aminotransferase to platelet ratio index; FIB-4, fibrosis index based on four factors; GPR, gamma-glutamyl transpeptidase to platelet ratio; NA, nucleoside/nucleotide analogue.